Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Preparation And Characterization Of Polymeric And Lipid Nanoparticles Of Pilocarpine HCl For Ocular Application
Genç Lütfi, Demirel Müzeyyen
Published 2013 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Pilocarpine is used topically in the treatment of glaucoma. Various studies were performed to improve the bioavailability and prolong the residence time of drugs in ocular drug delivery. Drug loaded polymeric and lipid nanoparticles offer several favourable biological properties, such as biodegradability, nontoxicity, biocompatibility and mucoadhesiveness. Therefore, preparing positively-charged pilocarpine HCl-loaded polymeric and lipid nanoparticles was the purpose of this study. Nanoparticles were prepared by quasi-emulsion solvent evaporation technique. The non-biodegradable positively-charged polymer Eudragit® RS 100 and semi-solid lipid excipient Gelucire® 44/14 were used as a vehicle, the cationic lipid octadecylamine was used as a cationic agent. The formulations were evaluated in terms of particle size, size distribution, zeta potential measurement, thermal behavior (Differential Scanning Calorimetry DSC), entrapment efficacy and pH. Characterizations of nanoparticles were analyzed during the storage period of 6 months for stability tests. Polymeric and lipid nanoparticles could be prepared successfully promising their use for ophthalmic delivery.
This paper references
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.
R. Cavalli (2002)
Introduction. Nanocarriers for Drug Delivery: Needs and Requirements
V. Torchilin (2006)
Nanoparticulate drug-deliver systems: an overview. drugs and the pharmaceutical sciences
D Thassu (2007)
Eudragit as controlled release system for anti-inflammatory drugs a comparison between DSC and dialysis experiments
F. Castelli (2003)
Nanoparticulate drug delivery
V. Patravale (2012)
Kinetics of the hydrolysis of pilocarpine in aqueous solution.
P. Chung (1970)
Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system
M. A. Kalam (2010)
Drugs and the pharmaceutical sciences
J. Swarbrick (1975)
Nanoparticulate Drug Delivery Systems
Deepak Thassu (2007)
Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles
J. Kattan (2004)
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.
Carolina Gómez-Gaete (2007)
Nanomedicines for ocular NSAIDs: safety on drug delivery.
J. Araújo (2009)
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium.
Tarl W. Prow (2008)
Hydrogel nanoparticles for drug delivery.
M. Dalby (2013)
Nanoparticulates as Drug Carriers
V. Torchilin (2006)
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Y. Diebold (2007)
The complete drug reference, Thirty-Second Edition
Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair
R. Cavalli (1995)
Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery.
Swarnali Das (2010)
Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations.
L. Budai (2007)
In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
S. Miyazaki (2001)
Nanoparticulate Drug-Delivery Systems: An Overview
Deepak Thassu (2007)
Polymeric and lipid nanoparticles of pilocarpine HCl 709
Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
P. Aksungur (2011)
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
R. Pignatello (2002)
Katı lipid nanopartiküller (SLN)
M Demirel (2000)
Studies on the effect of pilocarpine incorporation into a submicron emulsion on the stability of the drug and the vehicle.
K. Zurowska-Pryczkowska (1999)
A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma.
Qinghua Zhou (2009)
Steric stabilization II
R. Evans (1973)
Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery
E. Başaran (2010)
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
H. Gupta (2010)
Polymeric cyclosporine-A nanoparticles for ocular application.
E. Başaran (2011)
J. Shi (2002)
W. Stallings (2000)
Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels.
Yash Kapoor (2008)
Nanotechnology in ocular drug delivery.
S. Sahoo (2008)
Recent developments in the understanding of colloid stability
J. Overbeek (1977)
The Stationery Office
British Pharmacopoeia (2008)
Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
R. C. Nagarwal (2009)
A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
X. Li (2008)
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione.
A. Lopedota (2009)
Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo
Zhidong Liu (2011)
This paper is referenced by
NANOPARTICLES: A PROMISING DRUG DELIVERY APPROACH
R. Kadian (2018)
Lipid Nanocarrier: an Efficient Approach Towards Ocular Delivery of Hydrophilic Drug (Valacyclovir)
R. Kumar (2016)
Transdermal permeability of triamcinolone acetonide lipid nanoparticles
Zhenmiao Qin (2019)
Characterisation of 2-HP-β-cyclodextrin-PLGA nanoparticle complexes for potential use as ocular drug delivery vehicles
Fan Li (2019)
Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole
R. Kumar (2016)
Nanotechnological Interventions for Drug Delivery in Eye Diseases
A. Ingle (2017)
Analytical Techniques for the Assessment of Drug-Lipid Interactions and the Active Substance Distribution in Liquid Dispersions of Solid Lipid Microparticles (SLM) Produced de novo and Reconstituted from Spray-Dried Powders
E. Wolska (2020)
Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
R. Pignatello (2015)
INSTITUTO SUPERIOR DE CI NCIAS DA SA⁄DE
Egas Moniz (2014)
Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye.
M. Sharma (2016)
Vincristine and ɛ-viniferine-loaded PLGA-b-PEG nanoparticles: pharmaceutical characteristics, cellular uptake and cytotoxicity
Yüksel Öğünç (2017)
Strategies to prolong the residence time of drug delivery systems on ocular surface.
Brunella Grassiri (2020)
Polymers in Ophthalmology
J. A. Calles (2015)
Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part II ‐ Ocular drug‐loaded lipid nanoparticles
E. Sánchez-López (2017)
Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems
Iara Baldim (2020)